Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04078152
Title Durvalumab Long-Term Safety and Efficacy Study (WAVE)
Recruitment Active, not recruiting
Gender both
Phase FDA approved
Variant Requirements No
Sponsors AstraZeneca
Indications

Advanced Solid Tumor

Therapies

Durvalumab

Age Groups: adult | senior
Covered Countries USA | CAN


No variant requirements are available.